1. Atorvastatin Upregulates microRNA-186 and Inhibits the TLR4-Mediated MAPKs/NF-κB Pathway to Relieve Steroid-Induced Avascular Necrosis of the Femoral Head
   Yusong Zhang et al, 2021, Front. Pharmacol. CrossRef
2. Rivaroxaban Modulates TLR4/Myd88/NF-Kβ Signaling Pathway in a Dose-Dependent Manner With Suppression of Oxidative Stress and Inflammation in an Experimental Model of Depression
   Walaa Yehia Abdelzaher et al, 2021, Front. Pharmacol. CrossRef
3. Review article: current and emerging therapies for acute alcohol‐associated hepatitis
   Puru Rattan et al, 2022, Aliment Pharmacol Ther CrossRef
4. Experimental Assessment of Intestinal Damage in Controlled Donation After Circulatory Death for Visceral Transplantation
   Pablo Stringa et al, 2023, Transpl Int CrossRef
5. Semaglutide Attenuates Anxious and Depressive-Like Behaviors and Reverses the Cognitive Impairment in a Type 2 Diabetes Mellitus Mouse Model Via the Microbiota-Gut-Brain Axis
   Igor Henrique Rodrigues de Paiva et al, 2024, J Neuroimmune Pharmacol CrossRef
6. Sirt1/Nrf2/TNFα; TLR4/Myd88/NF-κB signaling pathways are involved in mediating hepatoprotective effect of bupropion in rat model of myocardial infarction
   Walaa Yehia Abdelzaher et al, 2024, Immunopharmacology and Immunotoxicology CrossRef